Current Good Manufacturing Practices | CHOP Research Institute
 

Current Good Manufacturing Practices

Cornerstone Blog

From Philly to Rio: CHOP’s Mission to Lower CAR-T Therapy Cost

Published on
Sep 25, 2024
CHOP Accelerates CAR-T Cell Manufacturing in Brazil
CHOP partnered with the National Cancer Institute of Brazil in an effort to provide cost-effective CAR-T cells to patients on a global scale.
Cornerstone Blog

Building on Nature's Delivery System to Advance Gene Therapy

Published on
Nov 5, 2021
Raymond G. Perelman Center for Cellular and Molecular Therapeutics
The Clinical Vector Core, an award-winning, state-of-the-art, multi-product GMP manufacturing facility, supports the growing field of gene therapy.

Clinical Vector Core

Photo of Clinical Vector Core Facility

The Raymond G. Perelman Center for Cellular and Molecular Therapeutics has established state-of-the-art Current Good Manufacturing Practices (cGMP) clinical vector manufacturing suites for adeno-associated virus (AAV) and lentiviral (LV) vectors.